Abstract
In this issue of Blood, Michel et al1 showed in a well-designed randomized controlled study that single unrelated cord blood transplantation (UCBT), with adequate cell dose, remains the standard of care. The single-unit UCBT arm had good survival (∼70%), low transplantation-related mortality (TRM: 5-6%), and a lower rate of extensive
... read more